| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 10/28/2004 | CA2522098A1 Absorption enhancers such as bht, bha or propylgallate |
| 10/28/2004 | CA2521979A1 Compositions and methods related to production of erythropoietin |
| 10/28/2004 | CA2521972A1 Skin protection composition comprising an extract of sasa |
| 10/28/2004 | CA2521655A1 Abuse-resistant oral dosage forms and method of use thereof |
| 10/28/2004 | CA2521420A1 Combination therapy for constipation comprising a laxative and a peripheral opioid antagonist |
| 10/28/2004 | CA2521403A1 Macromolecules auto-assembled and photopolymerised around carbon nanotubes a method for production and application thereof |
| 10/28/2004 | CA2521394A1 Pharmaceutical compositions for intranasal administration of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.o]non-1 (7)-en-2-yl)alkyl] phosphonic acid and derivatives and methods of use thereof |
| 10/28/2004 | CA2521379A1 Pharmaceutical formulations containing methylnaltrexone |
| 10/28/2004 | CA2521369A1 The use of peripheral opiois antagonists, especially methylnaltrexone to treat irritable bowel syndrome |
| 10/28/2004 | CA2521361A1 Chrono delivery formulations and method of treating atrial fibrillation |
| 10/28/2004 | CA2520970A1 Hemophilia treatment by inhalation of coagulation factors |
| 10/28/2004 | CA2520020A1 Venlafaxine compositions comprising pellets with double layer coating |
| 10/28/2004 | CA2517154A1 Compositions and methods for delivering thymosin beta 4, analogues, isoforms and other derivatives |
| 10/27/2004 | EP1471151A1 Improved method of producing lycopene through the fermentation of selected strains of blakeslea trispora, formulations and uses of the lycopene thus obtained |
| 10/27/2004 | EP1471059A1 S-triazine derivatives having 3 particular para-aminobenzalmalonate groups ;sunscreen compositions containing these derivatives; and their use |
| 10/27/2004 | EP1471034A2 Therapeutic calcium phosphate particles and methods of manufacture and use |
| 10/27/2004 | EP1470833A1 Dry powder delivery system |
| 10/27/2004 | EP1470826A1 Decoy-containing pharmaceutical compositions and method of using the same |
| 10/27/2004 | EP1470823A1 Polymer-clay nanocomposite for extended release of active ingredient |
| 10/27/2004 | EP1470819A1 High drug load mesalazine sachet |
| 10/27/2004 | EP1470816A2 Once-a-day metoprolol oral dosage form |
| 10/27/2004 | EP1470815A1 Opiod formulations for treating pain |
| 10/27/2004 | EP1470814A1 Process for the continuous production of inhalable medicaments |
| 10/27/2004 | EP1470562A2 Photovoltaic cell interconnection |
| 10/27/2004 | EP1470184A1 Device and method for producing a cross-linked substance, especially in the form of a microcapsule or layer |
| 10/27/2004 | EP1470152A1 Peptides for increasing transfection efficiency |
| 10/27/2004 | EP1469989A2 Amine functionalized superparamagnetic nanoparticles for the synthesis of bioconjugates and uses therefor |
| 10/27/2004 | EP1469941A2 Microparticles and methods for their production |
| 10/27/2004 | EP1469938A1 Apparatus and process for preparing crystalline particles |
| 10/27/2004 | EP1469903A2 Microneedle with membrane |
| 10/27/2004 | EP1469900A2 Humidity-tight cartridge for a powder inhaler |
| 10/27/2004 | EP1469887A2 Compositions and methods for use of bioactive agents derived from sulfated and sulfonated amino acids |
| 10/27/2004 | EP1469886A2 Pharmaceutical composition |
| 10/27/2004 | EP1469885A1 Parenteral composition of paracetamol |
| 10/27/2004 | EP1469858A1 Non-nucleosidic inhibitors of reverse transcriptase as antagonists of cell proliferation and inducers of cell differentiation |
| 10/27/2004 | EP1469848A1 Sedative non-benzodiazepine formulations |
| 10/27/2004 | EP1469846A2 Treatment of pain, inflammation, and inflammation-related disorders with a combination of a cyclooxygenase-2 selective inhibitor and aspirin |
| 10/27/2004 | EP1469840A1 Cyclosporin-containing sustained release pharmaceutical composition |
| 10/27/2004 | EP1469839A2 Transmucosal delivery of proton pump inhibitors |
| 10/27/2004 | EP1469838A1 Manufacture of oral dosage forms delivering both immediate release and sustained release drugs |
| 10/27/2004 | EP1469837A1 Bioadhesive composition comprising a polysaccharide and a polycarboxylated polymer |
| 10/27/2004 | EP1469836A1 Increased-dosage nelfinavir tablet and method of making same |
| 10/27/2004 | EP1469835A2 Stable salts of o-acetylsalicylic acid containing basic amino acids ii |
| 10/27/2004 | EP1469834A1 Multi-stage oral drug controlled-release system |
| 10/27/2004 | EP1469833A2 Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus |
| 10/27/2004 | EP1469832A1 Pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming materials |
| 10/27/2004 | EP1469831A1 Pharmaceutical compositions comprising a solid amorphous dispersion of cholesteryl ester transfer protein inhibitors |
| 10/27/2004 | EP1469830A2 Method for making homogeneous spray-dried solid amorphous drug dispersions using pressure nozzles |
| 10/27/2004 | EP1469829A2 Immediate release dosage forms containing solid drug dispersions |
| 10/27/2004 | EP1469828A2 Ophthalmic compositions including oil-in-water emulsions, and methods for making and using the same |
| 10/27/2004 | EP1469826A2 Osmotic delivery system |
| 10/27/2004 | EP1469825A1 Formulation for the administration of medicinal substances |
| 10/27/2004 | EP1469824A1 Pharmaceutical composition for extended/sustained release of therapeutically active ingredient |
| 10/27/2004 | EP1469812A2 Oral insulin therapy |
| 10/27/2004 | EP1469747A1 Isotropic transparent compositions containing fat soluble vitamin |
| 10/27/2004 | EP1469745A1 Use of multi-layer pigments in the food and pharmaceutical industry |
| 10/27/2004 | EP1469743A1 Stable hygroscopic compositions and methods for stabilizing hygroscopic ingredients |
| 10/27/2004 | EP1469739A1 Chewing gum and confectionery compositions with encapsulated stain removing agent compositions, and methods of making and using the same |
| 10/27/2004 | EP1469732A1 Methods for preserving ophthalmic solutions and preserved ophtalmic solutions |
| 10/27/2004 | EP1322275A4 Ultrasonic method and device for wound treatment |
| 10/27/2004 | EP1250050B1 Method and device for sanitation using bacteriophages |
| 10/27/2004 | EP1232188B1 Cyclodextrins substituted by fluoroalkyl groups, preparation and use thereof |
| 10/27/2004 | EP1212061B1 Injectable buprenorphine microparticle compositions and their use in reducing consumption of heroin and alcohol |
| 10/27/2004 | EP1204407B1 Implantable active ingredient depot |
| 10/27/2004 | EP1161218B1 Method for making pharmaceutical tablets by compression |
| 10/27/2004 | EP1107777B1 Stabilized pharmaceutical composition in lyophilized form |
| 10/27/2004 | EP1085858B1 Transdermal therapeutic system for the administration of candesartan |
| 10/27/2004 | EP0952807B1 Anti-viral, anhydrous, and mild skin lotions for application to tissue paper products |
| 10/27/2004 | EP0914091B9 Ethene containing solutions and use thereof in methods of therapy or prophylaxis |
| 10/27/2004 | EP0900565B1 Patch containing isosorbide dinitrate |
| 10/27/2004 | EP0832270B1 Cationic lipid:dna complexes for gene targeting |
| 10/27/2004 | EP0831791B1 Delivery of drugs to the lower gi tract |
| 10/27/2004 | EP0782862B1 Genetic material containing composition |
| 10/27/2004 | EP0746338B1 Vaccines containing paucilamellar lipid vesicles as immunological adjuvants |
| 10/27/2004 | CN2650763Y Paste with medicine storage |
| 10/27/2004 | CN1541129A Azeotrope-like compsns. of tetrafluoroethane, pentafluoropropane and water |
| 10/27/2004 | CN1541127A Pellet implant system and method of administration |
| 10/27/2004 | CN1541126A Microprojection array having beneficial agent contg coating |
| 10/27/2004 | CN1541112A Percutaneous absorption preparations |
| 10/27/2004 | CN1541095A 抑制炎症的化合物 The compounds inhibit inflammation |
| 10/27/2004 | CN1541092A Method for treating primary insomnia |
| 10/27/2004 | CN1541091A Pharmaceutical prepn. in form of suspension comprising acid-labile active ingredient |
| 10/27/2004 | CN1541090A Prepn. of sustained release pharmaceutical compsn. |
| 10/27/2004 | CN1541058A Cultivated agarwood |
| 10/27/2004 | CN1539967A A group of nucleotide sequence for anti infection of coronavirus and preventing SARS and application |
| 10/27/2004 | CN1539844A 2,3,5,4'-tetrahydroxy diphenyl ethylene-2-1-beta-D-glucoside |
| 10/27/2004 | CN1539501A Tablet for keeping in mouth prepared from recombined human interferon alpha 2b and producing method |
| 10/27/2004 | CN1539499A Combination of stable interferon for lacal use |
| 10/27/2004 | CN1539495A First aid prescription for preventing and curing all pestilences |
| 10/27/2004 | CN1539494A Chinese traditional medicine for raising immunocompetence of body for anti influenza, SARS, and preparation method |
| 10/27/2004 | CN1539493A Combination of Chinese traditional medicine for curing disease of respiratory system and preparing method |
| 10/27/2004 | CN1539492A Medication for treating astriv disease, gastric ulcer and preparation technique |
| 10/27/2004 | CN1539491A Chinese traditional medicine for upper respiratory tract infection |
| 10/27/2004 | CN1539488A Suction stick fighting against senium and tonifying the kidney |
| 10/27/2004 | CN1539487A Suction stick for reducing fever, relieving sore-throat and anti diarrhea |
| 10/27/2004 | CN1539486A Stick of sucking incense for reducing fever and antivirus |
| 10/27/2004 | CN1539483A Chinese traditional medicine for treating chronic liver disease and anti hepatic fibrosis |
| 10/27/2004 | CN1539482A Naristillae for curing rhinopathy |
| 10/27/2004 | CN1539481A Method for preparing injection of oleum functus brucease |
| 10/27/2004 | CN1539478A Medication for treating psoriasis and preparation method |